Nurix Therapeutics GAAP EPS of $4.73 beats by $1.64, revenue of $673.1M beats by $193.58M (NASDAQ:NRIX)
· seekingalpha.com
Nurix Therapeutics press release (NRIX): Q3 GAAP EPS of $4.73 beats by $1.64. Revenue of $673.1M (+8420.3% Y/Y) beats by $193.58M. Cash, cash equivalents and ma
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...